We are proud to announce that OYSTA has been honored with the prestigious iF Design Award for its excellence in digital innovation and user-centric design.
This award is a testament to our shared vision and collaborative efforts of our partners—global life science company OnDosis AB and global technology consultancy Star—to redefine medication management for ADHD and beyond.
Improving ADHD care with digital innovation
OYSTA is more than a product—it’s a transformative solution designed to support medication adherence and enhance the care experience for young patients. By combining pharmaceutical expertise with e-health technology, OYSTA integrates two key components: the OYSTA Dosage Manager and the OYSTA Digital Service. Together, they enable intuitive, precise and flexible dosing, while providing connected care for patients, healthcare providers, teachers and carers.
The OYSTA Digital Service empowers effective ADHD management through tools for medication adherence, real-time data tracking and personalized insights. This breakthrough in personalized medication management improves the treatment experience for young patients and their circle of care.
A collaborative achievement setting a new standard in digital health
This transformative solution was made possible through the collaboration of OnDosis, who led its development, Tiefenbacher Group, which contributed its pharmaceutical expertise, and Star, which designed and built the OYSTA Digital Service—ensuring seamless integration between the physical dosing device and the digital ecosystem.
ADHD treatment is a complex, highly individualized process that requires precise dosage adjustments and continuous monitoring. OYSTA exemplifies an innovative healthcare solution that not only meets medical and technical standards but also prioritizes the needs of patients and healthcare providers. This milestone reflects our collective dedication to creating a patient-centric solution that sets a new standard in digital health—one that is both effective and accessible.
For more information about OYSTA, visit oysta-health.com.
Explore the work of our partners OnDosis at https://www.ondosis.com/ and Star at star.global
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
